Position in SOLV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,800,565
+$2,179,748 QoQ
Shares Held
269,612
-5.5% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 875 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SOLV Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $713,213,728 across 40 Medical Instruments & Supplies names. SOLV ranks #12 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ISRG |
Intuitive Surgical Inc
|
587,223 | $233,526,842 | |
| 2 | WST |
West Pharmaceutical Services Inc
|
257,112 | $92,303,208 | |
| 3 | BDX |
Becton Dickinson & Co
|
449,784 | $68,065,812 | |
| 4 | RMD |
Resmed Inc
|
328,330 | $63,984,950 | |
| 5 | TFX |
Teleflex Inc
|
305,197 | $38,686,771 | |
| 6 | BAX |
Baxter International Inc
|
1,663,662 | $35,469,273 | |
| 7 | COO |
Cooper Companies, Inc.
|
384,593 | $27,579,164 | |
| 8 | WRBY |
Warby Parker Inc.
|
899,277 | $27,284,064 |
All Filings in SOLV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,800,565 | 269,612 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,620,817 | 285,158 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $20,891,467 | 263,648 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $19,557,941 | 267,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,363,369 | 281,690 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,421,832 | 255,416 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,164,815 | 244,699 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,255,590 | 175,783 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,120,861 | 191,393 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||